You have 7 free searches left this month | for more free features.

Leber's Hereditary Optic Neuropathy,11778 LHON mutation,

Showing 1 - 25 of 5,519

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Placebo)

Active, not recruiting
  • Leber Hereditary Optic Neuropathy
  • GS010
  • Placebo
  • Pasadena, California
  • +12 more
Aug 2, 2022

Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

Not yet recruiting
  • Leber Hereditary Optic Neuropathy (LHON)
  • NFS-02 Injection
  • (no location specified)
Apr 6, 2023

Disease and Visual Disability on Quality of Life and Loss of

Recruiting
  • Leber's Hereditary Optic Neuropathy (LHON)
    • Orléans, France
      Argo Sante
    Sep 22, 2022

    Trial

    Not yet recruiting
    • Leber Hereditary Optic Neuropathy (LHON)
    • NR082 Injection
    • Injection needle
    • (no location specified)
    Jan 30, 2023

    Leber's Hereditary Optic Neuropathy Trial in Miami (injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),, injection of scAAV2-P1ND4v2

    Active, not recruiting
    • Leber's Hereditary Optic Neuropathy
    • injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),
    • +3 more
    • Miami, Florida
      Bascom Palmer Eye Institute, University of Miami
    Jul 1, 2021

    Leber's Hereditary Optic Neuropathy (LHON) Trial in Beijing (NR082 injection, Sham Injection)

    Recruiting
    • Leber's Hereditary Optic Neuropathy (LHON)
    • NR082 injection
    • Sham Injection
    • Beijing, China
      Beijing Tongren Hospital, Capital Medical University
    Dec 21, 2021

    Leber's Hereditary Optic Neuropathy Trial in Pasadena (elamipretide (MTP-131) 1% topical ophthalmic solution, Vehicle topical

    Completed
    • Leber's Hereditary Optic Neuropathy
    • elamipretide (MTP-131) 1% topical ophthalmic solution
    • Vehicle topical ophthalmic solution
    • Pasadena, California
      Doheny Eye Center
    Nov 29, 2021

    Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber) Trial (GS010)

    Available
    • Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
    • GS010
    • (no location specified)
    Aug 2, 2021

    Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Sham)

    Completed
    • Leber Hereditary Optic Neuropathy
    • GS010
    • Sham
    • Pasadena, California
    • +6 more
    Jul 25, 2022

    Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

    Recruiting
    • Retinal Disease
    • +17 more
    • Arm 1
    • Westport, Connecticut
    • +2 more
    Nov 25, 2022

    Ischemic Optic Neuropathy, Branch Retinal Artery Occlusion, Hemianopia Trial in Iowa City (LSFG-NAVI)

    Recruiting
    • Ischemic Optic Neuropathy
    • +4 more
    • LSFG-NAVI
    • Iowa City, Iowa
      University of Iowa Department of Ophthalmology
    Jul 4, 2022

    Safety Issues, Efficacy, Self Trial in Paris (Béfizal)

    Recruiting
    • Safety Issues
    • Efficacy, Self
    • Paris, France
      HEGP Hospital
    Feb 9, 2021

    Leber Hereditary Optic Neuropathy Trial in Wuhan (rAAV2-ND4)

    Active, not recruiting
    • Leber Hereditary Optic Neuropathy
    • Wuhan, Hubei, China
      Department of Ophthalmology,Tongji Hospital, Tongji Medical Coll
    Sep 15, 2020

    Post Authorisation Safety Study With Raxone in LHON Patients

    Completed
    • Leber's Hereditary Optic Neuropathy (LHON)
    • Graz, Austria
    • +25 more
    Jul 15, 2021

    Leber Hereditary Optic Neuropathy Trial in Worldwide (Patient-reported outcomes (PROs))

    Completed
    • Leber Hereditary Optic Neuropathy
    • Patient-reported outcomes (PROs)
    • Pasadena, California
    • +10 more
    Feb 3, 2021

    Leber's Hereditary Optic Neuropathy (LHON) Trial in Worldwide (Idebenone)

    Completed
    • Leber's Hereditary Optic Neuropathy (LHON)
    • Phoenix, Arizona
    • +28 more
    Jul 15, 2021

    Acute LHON, Onset Within Three Months, Onset Between 3 to 6 Months Trial in Wuhan (rAAV2-ND4)

    Unknown status
    • Acute LHON
    • +6 more
    • Wuhan, Hubei, China
      Department of Ophthalmology ,Tongji Hospital, Tongji Medical Col
    Jul 27, 2020

    Leber Hereditary Optic Neuropathy Trial in Paris (GS010)

    Completed
    • Leber Hereditary Optic Neuropathy
    • GS010
    • Paris, France
      CIC du CHNO DES QUINZE-VINGTS
    Jun 30, 2020

    Retinitis Pigmentosa, Leber's Hereditary Optic Neuropathy, Stargardt Disease Trial in Paris (Dynamic pupillometry sessions)

    Completed
    • Retinitis Pigmentosa
    • +2 more
    • Dynamic pupillometry sessions
    • Paris, France
      Centre Hospitalier National D'Ophtalùmologie des Quinze-Vingts
    May 28, 2021

    Leber's Hereditary Optic Neuropathy Trial (Idebenone 150 MG Oral Tablet)

    Available
    • Leber's Hereditary Optic Neuropathy
    • Idebenone 150 MG Oral Tablet
    • (no location specified)
    May 5, 2020

    Visual Acuity Data From Leber's Hereditary Optic Neuropathy

    Completed
    • Leber's Hereditary Optic Neuropathy (LHON)
      • Brussels, Belgium
      • +20 more
      Jan 20, 2020

      Nicotinamide Adverse Reaction Trial (Nicotinamide)

      Not yet recruiting
      • Nicotinamide Adverse Reaction
      • (no location specified)
      Aug 29, 2023

      Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)

      Recruiting
      • Neurodegenerative Disease, Hereditary
      • +2 more
      • Mutation analysis
      • Buffalo, New York
        UBMD Pediatrics
      Mar 3, 2022

      Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

      Recruiting
      • Rare Disorders
      • +309 more
        • Sioux Falls, South Dakota
        • +1 more
        Jun 20, 2022

        Mitochondrial Diseases, Pearson Syndrome Trial in Ramat Gan (MNV-201)

        Recruiting
        • Mitochondrial Diseases
        • Pearson Syndrome
        • MNV-201
        • Ramat Gan, Israel
          Sheba Medical Center
        Aug 24, 2023